Tarsus Pharmaceuticals
TARS
TARS
69 hedge funds and large institutions have $298M invested in Tarsus Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
8% less funds holding
Funds holding: 75 → 69 (-6)
15% less capital invested
Capital invested by funds: $351M → $298M (-$52.7M)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
Holders
69
Holding in Top 10
2
Calls
$870K
Puts
$3K
Top Buyers
| 1 | +$7.7M | |
| 2 | +$6.53M | |
| 3 | +$4.06M | |
| 4 |
BlackRock
New York
|
+$3.26M |
| 5 |
State Street
Boston,
Massachusetts
|
+$785K |
Top Sellers
| 1 | -$8.94M | |
| 2 | -$3.45M | |
| 3 | -$1.49M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
-$1.33M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.29M |